Advertisement
UK markets close in 6 hours 52 minutes
  • FTSE 100

    8,094.27
    +53.89 (+0.67%)
     
  • FTSE 250

    19,696.97
    -22.40 (-0.11%)
     
  • AIM

    754.58
    -0.11 (-0.01%)
     
  • GBP/EUR

    1.1671
    +0.0026 (+0.22%)
     
  • GBP/USD

    1.2520
    +0.0057 (+0.46%)
     
  • Bitcoin GBP

    50,960.95
    -2,303.86 (-4.33%)
     
  • CMC Crypto 200

    1,365.63
    -16.94 (-1.23%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.23
    +0.42 (+0.51%)
     
  • GOLD FUTURES

    2,337.70
    -0.70 (-0.03%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    18,019.00
    -69.70 (-0.39%)
     
  • CAC 40

    8,064.18
    -27.68 (-0.34%)
     

Moderna Starts a Phase 2 Clinical Trial for Its COVID-19 Vaccine

Moderna Starts a Phase 2 Clinical Trial for Its COVID-19 Vaccine

Moderna (NASDAQ: MRNA) has enrolled the first participants in a phase 2 clinical trial testing mRNA-1273, its vaccine against the novel coronavirus that causes COVID-19. Moderna announced plans to start the mid-stage study in April, followed by an endorsement by the Food and Drug Administration last month. Moderna plans to enroll 600 participants in the study, with half of them being 55 years of age or older.